Invention Grant
- Patent Title: Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
-
Application No.: US15336208Application Date: 2016-10-27
-
Publication No.: US10278940B2Publication Date: 2019-05-07
- Inventor: Pedro Cuevas Sànchez , Guillermo Gimenez Gallego , Inigo Saenz de Tejada Gorman , Javier Angulo Frutos , Serafin Valverde Lopez , Antonio Romero Garrido , Rosa Maria Lozano Puerto
- Applicant: AmDerma Pharmaceuticals, LLC
- Applicant Address: US NJ Bridgewater
- Assignee: AmDerma Pharmaceuticals, LLC
- Current Assignee: AmDerma Pharmaceuticals, LLC
- Current Assignee Address: US NJ Bridgewater
- Agency: Servilla Whitney LLC
- Priority: ES200602218 20060816; ES200701856 20070702
- Main IPC: A61K31/216
- IPC: A61K31/216 ; A61K31/255 ; A61K31/185 ; A61K31/192 ; A61K31/222 ; A61K45/06 ; A61K31/225 ; C07C59/68 ; C07C309/24 ; C07C309/42 ; C07C309/68 ; C07C309/75 ; A61K31/235 ; C07C57/44 ; C07C65/03 ; C07C65/19 ; C07C69/017 ; C07C69/84 ; A61K31/10 ; A61K9/00 ; A61K31/095
Abstract:
The present invention relates to the use of a 2,5-dihydroxybenzene derivative of formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of, inter alia, skin cancer.
Public/Granted literature
- US20170065547A1 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer Public/Granted day:2017-03-09
Information query
